Select Page

Press Release

Sun Pharma receives DCGI approval for Molxvir® (Molnupiravir) in India

Press Release

Sun Pharma Completes Taro Merger

The Sun Story

Watch the inspiring growth story of Sun – from humble beginnings in 1983 with just 2 employees and 5 psychiatry products to becoming the 4th largest global generic pharmaceutical company, selling over 2000 products in over 100 countries.

SunPharma on Twitter

Engaging panel at the 9th #GPQS2024 on 'Enhancing Current Cybersecurity: Securing the Digital Future' featuring Phani Mitra B (@drreddys), Sreeji Gopinathan (@LupinGlobal), Dheeraj Sinha (@SunPharma_Live), & Sanjay Moralwar (@ZydusUniverse).

Proud moment for Sun! We've got not one but two feathers in our cap with @GPTW_India recognizing us as one of India's 50 Best Companies to Work For & Best Employers Among Nation-Builders 2024.
#bestemployersamoungnationbuilders #Indiasbestcompaniestoworkfor #GPTWCertified

We are pleased to announce the successful completion of the merger of Taro with Sun Pharma.

Read more here: https://bit.ly/pressreleasetaromerger

The results from a Phase I study evaluating the safety, tolerability, pharmacokinetics & pharmacodynamics of our GL0034 (Utreglutide) in obese adults, were presented at the 84th Scientific Sessions of the American Diabetes Association (ADA).
https://bit.ly/45FqtcO

Sun Pharma has entered into a non-exclusive patent licensing agreement with Japanese pharmaceutical company, Takeda to introduce a novel Gastrointestinal Drug, Voltapraz (Vonoprazan) in India.

Read more here: https://bit.ly/3xoMY99

Happy International Yoga Day!

Whether you're at your work desk or at home, take a break, breathe deeply, and feel the difference.

#InternationalYogaDay

As a part of #AcneAwarenessMonth, our U.S team hosted an event in New York with Dr. Sandra Lee.
She continues to collaborate with Sun Pharma to educate consumers on the role of sebum in causing acne breakouts through informative ‘edutainment.’ Read more: http://bit.ly/4ctrmHr

4

Sun Pharma & Moebius Medical Limited today presented data demonstrating the durability of pain relief achieved in symptomatic knee OA patients through 26 weeks post injection of MM-II at the European Alliance of Associations for Rheumatology (EULAR) 2024. http://bit.ly/4cnqqEj

Load More

Find out more

Innovation

Science is at the heart of Sun Pharma. Our scientists work closely with doctors, patients, and business development teams, to generate innovative concepts and ideas to harness market needs and synergies across therapeutic areas.

Quality

Our vision is to globalize, harmonize and simplify GxP processes to achieve a sustainable quality culture.

Careers

We hire exceptionally talented individuals, and ensure they are nurtured professionally. Our multi-dimensional work environment offers high growth opportunities through challenging roles with clear responsibilities.

Responsibility

Our CSR efforts are focused on serving and helping needy and underprivileged communities. Our priority areas include: health, education, drinking water and sanitation.

Sun Pharma offers a program for individuals who want to disclose violations of US FDA requirements related to facilities or products owned or operated by Ranbaxy prior to Sun Pharma acquisition of Ranbaxy. Continue
Top